{"hands_on_practices": [{"introduction": "This exercise grounds the theory in calculation by having you compute predictive values for a single test across three different populations. You will directly observe and quantify how dramatically the Positive Predictive Value ($PPV$) changes with prevalence, reinforcing the core principle that a test's utility is inseparable from the population's underlying disease frequency [@problem_id:4602486].", "problem": "A single screening test for a binary disease outcome is deployed in three populations that differ only in their disease prevalence. The test has sensitivity $Se = 0.95$ and specificity $Sp = 0.98$. Let the prevalence (pre-test probability of disease) be $\\pi \\in \\{0.001,\\,0.01,\\,0.1\\}$. Starting from Bayes’ theorem and the odds-based framework for belief updating (pre-test odds multiplied by a likelihood ratio yields post-test odds), derive expressions for the positive predictive value (posterior probability of disease given a positive test result, PPV) and the negative predictive value (posterior probability of no disease given a negative test result, NPV) in terms of $Se$, $Sp$, and $\\pi$. Then evaluate PPV and NPV for each value of $\\pi$. Report your six numerical values in the order $(PPV_{0.001},\\,PPV_{0.01},\\,PPV_{0.1},\\,NPV_{0.001},\\,NPV_{0.01},\\,NPV_{0.1})$. Round your numerical answers to four significant figures. Express all values as unitless decimals (do not use a percentage sign). Finally, briefly comment on the magnitude and direction of changes in PPV and NPV across the three prevalences.", "solution": "This problem is scientifically grounded, well-posed, and objective. All necessary data are provided, and the task is a standard application of Bayesian statistics in epidemiology. We may proceed with the solution.\n\nLet $D$ be the event that an individual has the disease and $D^c$ be the event they do not. Let $T^+$ be a positive test result and $T^-$ be a negative test result. We are given the following definitions and values:\nPrevalence (pre-test probability of disease): $\\pi = P(D)$, with values $\\pi \\in \\{0.001, 0.01, 0.1\\}$.\nSensitivity: $Se = P(T^+ | D) = 0.95$.\nSpecificity: $Sp = P(T^- | D^c) = 0.98$.\n\nFrom these, we can state the probabilities of complementary events:\nProbability of not having the disease: $P(D^c) = 1 - \\pi$.\nFalse positive rate (Type I error): $P(T^+ | D^c) = 1 - Sp = 1 - 0.98 = 0.02$.\nFalse negative rate (Type II error): $P(T^- | D) = 1 - Se = 1 - 0.95 = 0.05$.\n\nThe problem requires deriving expressions for the positive predictive value ($PPV$) and negative predictive value ($NPV$) using the odds-based framework.\n\nThe pre-test odds of disease are the ratio of the probability of having the disease to the probability of not having it:\n$$\nO_{pre} = \\frac{P(D)}{P(D^c)} = \\frac{\\pi}{1 - \\pi}\n$$\n\nThe likelihood ratio for a positive test ($LR+$) is the ratio of the probability of a positive test in a diseased individual to the probability of a positive test in a non-diseased individual:\n$$\nLR+ = \\frac{P(T^+ | D)}{P(T^+ | D^c)} = \\frac{Se}{1 - Sp}\n$$\n\nThe likelihood ratio for a negative test ($LR-$) is the ratio of the probability of a negative test in a diseased individual to the probability of a negative test in a non-diseased individual:\n$$\nLR- = \\frac{P(T^- | D)}{P(T^- | D^c)} = \\frac{1 - Se}{Sp}\n$$\n\nBayes' theorem in odds form states that the post-test odds are the pre-test odds multiplied by the likelihood ratio. For a positive test, the post-test odds of disease are:\n$$\nO_{post,+} = O_{pre} \\times LR+ = \\left(\\frac{\\pi}{1 - \\pi}\\right) \\left(\\frac{Se}{1 - Sp}\\right)\n$$\n\nThe positive predictive value, $PPV = P(D | T^+)$, is the probability corresponding to these post-test odds. The conversion from odds ($O$) to probability ($P$) is $P = \\frac{O}{1 + O}$.\n$$\nPPV = \\frac{O_{post,+}}{1 + O_{post,+}} = \\frac{\\left(\\frac{\\pi}{1 - \\pi}\\right) \\left(\\frac{Se}{1 - Sp}\\right)}{1 + \\left(\\frac{\\pi}{1 - \\pi}\\right) \\left(\\frac{Se}{1 - Sp}\\right)}\n$$\nMultiplying the numerator and denominator by $(1 - \\pi)(1 - Sp)$ gives the standard expression for $PPV$:\n$$\nPPV = \\frac{\\pi Se}{(1 - \\pi)(1 - Sp) + \\pi Se}\n$$\n\nFor a negative test, the post-test odds of disease are:\n$$\nO_{post,-} = O_{pre} \\times LR- = \\left(\\frac{\\pi}{1 - \\pi}\\right) \\left(\\frac{1 - Se}{Sp}\\right)\n$$\nThis gives the probability of disease given a negative test, $P(D | T^-) = \\frac{O_{post,-}}{1 + O_{post,-}}$.\nThe negative predictive value, $NPV = P(D^c | T^-)$, is the probability of *not* having the disease given a negative test. This is the complement of $P(D | T^-)$.\n$$\nNPV = 1 - P(D | T^-) = 1 - \\frac{O_{post,-}}{1 + O_{post,-}} = \\frac{1}{1 + O_{post,-}}\n$$\nSubstituting the expression for $O_{post,-}$:\n$$\nNPV = \\frac{1}{1 + \\left(\\frac{\\pi}{1 - \\pi}\\right) \\left(\\frac{1 - Se}{Sp}\\right)}\n$$\nMultiplying the numerator and denominator by $(1 - \\pi)Sp$ gives the standard expression for $NPV$:\n$$\nNPV = \\frac{(1 - \\pi)Sp}{(1 - \\pi)Sp + \\pi(1 - Se)}\n$$\n\nNow we evaluate $PPV$ and $NPV$ for each given prevalence $\\pi$.\nWe have $Se = 0.95$, $Sp = 0.98$, $1-Se = 0.05$, and $1-Sp = 0.02$.\n\nCase 1: $\\pi = 0.001$\n$$\nPPV_{0.001} = \\frac{0.001 \\times 0.95}{0.001 \\times 0.95 + (1 - 0.001) \\times 0.02} = \\frac{0.00095}{0.00095 + 0.999 \\times 0.02} = \\frac{0.00095}{0.00095 + 0.01998} = \\frac{0.00095}{0.02093} \\approx 0.04539\n$$\n$$\nNPV_{0.001} = \\frac{(1 - 0.001) \\times 0.98}{(1 - 0.001) \\times 0.98 + 0.001 \\times 0.05} = \\frac{0.999 \\times 0.98}{0.999 \\times 0.98 + 0.00005} = \\frac{0.97902}{0.97902 + 0.00005} = \\frac{0.97902}{0.97907} \\approx 0.9999\n$$\n\nCase 2: $\\pi = 0.01$\n$$\nPPV_{0.01} = \\frac{0.01 \\times 0.95}{0.01 \\times 0.95 + (1 - 0.01) \\times 0.02} = \\frac{0.0095}{0.0095 + 0.99 \\times 0.02} = \\frac{0.0095}{0.0095 + 0.0198} = \\frac{0.0095}{0.0293} \\approx 0.3242\n$$\n$$\nNPV_{0.01} = \\frac{(1 - 0.01) \\times 0.98}{(1 - 0.01) \\times 0.98 + 0.01 \\times 0.05} = \\frac{0.99 \\times 0.98}{0.99 \\times 0.98 + 0.0005} = \\frac{0.9702}{0.9702 + 0.0005} = \\frac{0.9702}{0.9707} \\approx 0.9995\n$$\n\nCase 3: $\\pi = 0.1$\n$$\nPPV_{0.1} = \\frac{0.1 \\times 0.95}{0.1 \\times 0.95 + (1 - 0.1) \\times 0.02} = \\frac{0.095}{0.095 + 0.9 \\times 0.02} = \\frac{0.095}{0.095 + 0.018} = \\frac{0.095}{0.113} \\approx 0.8407\n$$\n$$\nNPV_{0.1} = \\frac{(1 - 0.1) \\times 0.98}{(1 - 0.1) \\times 0.98 + 0.1 \\times 0.05} = \\frac{0.9 \\times 0.98}{0.9 \\times 0.98 + 0.005} = \\frac{0.882}{0.882 + 0.005} = \\frac{0.882}{0.887} \\approx 0.9944\n$$\n\nCommentary on the results:\nThe positive predictive value (PPV) is strongly dependent on prevalence. As prevalence increases from $0.001$ to $0.1$, the PPV increases dramatically from approximately $4.5\\%$ to $84.1\\%$. This illustrates that a positive result from a screening test is far more likely to be a true positive in a high-prevalence setting than in a low-prevalence setting.\nConversely, the negative predictive value (NPV) is less sensitive to changes in prevalence, especially when the test is highly specific. As prevalence increases from $0.001$ to $0.1$, the NPV decreases, but only slightly, from $0.9999$ to $0.9944$. A negative result provides strong evidence for the absence of disease across all three prevalence settings.", "answer": "$$\\boxed{\\begin{pmatrix} 0.04539 & 0.3242 & 0.8407 & 0.9999 & 0.9995 & 0.9944 \\end{pmatrix}}$$", "id": "4602486"}, {"introduction": "This practice shifts the perspective from analysis to design by asking a crucial question for public health. You will calculate the minimum specificity ($Sp$) a test must achieve to be effective for screening a rare disease, directly confronting the technical challenge posed by low-prevalence settings [@problem_id:4602477].", "problem": "A laboratory is considering deploying a screening test for a rare infectious disease in an asymptomatic population. The population-level prevalence is $\\pi = 0.001$. The test has sensitivity (true positive rate) $Se = 0.95$ and specificity (true negative rate) $Sp$ to be determined. The laboratory’s policy is to require that the positive predictive value (PPV), the probability of disease given a positive test, be at least $0.5$ before adopting a test for screening. Starting only from the fundamental definition of conditional probability, the law of total probability, and Bayes’ theorem, derive the condition on $Sp$ that guarantees $\\mathrm{PPV} \\ge 0.5$ in terms of $\\pi$ and $Se$, and then compute the minimum $Sp$ needed given $\\pi = 0.001$ and $Se = 0.95$. Briefly explain, using the structure of the derived condition, why meeting this requirement is practically difficult in low-prevalence screening. Express the final numerical value of the minimum $Sp$ as a decimal (not a percent), rounded to $6$ significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n**Step 1: Extract Givens**\n- Population prevalence: $\\pi = 0.001$\n- Test sensitivity (true positive rate): $Se = 0.95$\n- Test specificity (true negative rate): $Sp$\n- Policy requirement: Positive Predictive Value $(\\mathrm{PPV}) \\ge 0.5$\n- Objective: Derive the condition on $Sp$ to meet the $\\mathrm{PPV}$ requirement, compute the minimum $Sp$, and explain the practical difficulty in low-prevalence screening.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is a standard application of Bayesian probability theory to the fields of epidemiology and diagnostic medicine. The variables—prevalence, sensitivity, specificity, and positive predictive value—are fundamental, well-defined concepts. The given numerical values are realistic for a rare disease screening scenario. The problem is self-contained, logically consistent, and asks for a formal derivation and calculation based on provided data, followed by a conceptual explanation grounded in the derived result. There are no scientific or factual unsoundness, no ambiguity, and no missing information.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A solution will be constructed.\n\n**Derivation of the Condition on Specificity ($Sp$)**\n\nLet $D$ be the event that an individual has the disease, and let $D^c$ be the event that they do not. Let $T^+$ be the event of a positive test result. The given information can be formally stated as:\n- Prevalence: $P(D) = \\pi$\n- Probability of no disease: $P(D^c) = 1 - P(D) = 1 - \\pi$\n- Sensitivity: $Se = P(T^+ | D)$\n- Specificity: $Sp = P(T^- | D^c)$, where $T^-$ is a negative test result. The false positive rate is therefore $P(T^+ | D^c) = 1 - P(T^- | D^c) = 1 - Sp$.\n\nThe Positive Predictive Value ($\\mathrm{PPV}$) is the probability of having the disease given a positive test result, $P(D | T^+)$. We start with the fundamental definition of conditional probability, which forms the basis of Bayes' theorem:\n$$ \\mathrm{PPV} = P(D | T^+) = \\frac{P(D \\cap T^+)}{P(T^+)} $$\nThe numerator, the joint probability of having the disease and testing positive, can be expressed using the definition of sensitivity:\n$$ P(D \\cap T^+) = P(T^+ | D) P(D) = Se \\cdot \\pi $$\nThe denominator, the overall probability of a positive test, is found using the law of total probability, by summing over the mutually exclusive states of having the disease or not:\n$$ P(T^+) = P(T^+ | D) P(D) + P(T^+ | D^c) P(D^c) $$\nSubstituting the defined terms:\n$$ P(T^+) = (Se)(\\pi) + (1 - Sp)(1 - \\pi) $$\nCombining these expressions gives the full formula for $\\mathrm{PPV}$:\n$$ \\mathrm{PPV} = \\frac{Se \\cdot \\pi}{Se \\cdot \\pi + (1 - Sp)(1 - \\pi)} $$\nThe laboratory's policy requires $\\mathrm{PPV} \\ge 0.5$. We establish the inequality:\n$$ \\frac{Se \\cdot \\pi}{Se \\cdot \\pi + (1 - Sp)(1 - \\pi)} \\ge 0.5 $$\nSince the denominator is a sum of probabilities of non-zero events, it is strictly positive. We can multiply both sides by the denominator without altering the inequality's direction:\n$$ Se \\cdot \\pi \\ge 0.5 \\left( Se \\cdot \\pi + (1 - Sp)(1 - \\pi) \\right) $$\n$$ 2 \\cdot Se \\cdot \\pi \\ge Se \\cdot \\pi + (1 - Sp)(1 - \\pi) $$\nSubtracting $Se \\cdot \\pi$ from both sides:\n$$ Se \\cdot \\pi \\ge (1 - Sp)(1 - \\pi) $$\nTo solve for $Sp$, we first isolate the term $(1 - Sp)$. Since $\\pi < 1$, the term $(1 - \\pi)$ is positive, so we can divide by it:\n$$ \\frac{Se \\cdot \\pi}{1 - \\pi} \\ge 1 - Sp $$\nFinally, rearranging the inequality to solve for $Sp$:\n$$ Sp \\ge 1 - \\frac{Se \\cdot \\pi}{1 - \\pi} $$\nThis is the required condition on $Sp$ that guarantees $\\mathrm{PPV} \\ge 0.5$.\n\n**Calculation of Minimum Specificity ($Sp$)**\n\nThe minimum specificity, $Sp_{min}$, is the value at the boundary of the derived condition. We substitute the given values, $\\pi = 0.001$ and $Se = 0.95$, into the expression:\n$$ Sp_{min} = 1 - \\frac{Se \\cdot \\pi}{1 - \\pi} = 1 - \\frac{(0.95)(0.001)}{1 - 0.001} $$\n$$ Sp_{min} = 1 - \\frac{0.00095}{0.999} $$\n$$ Sp_{min} = 1 - 0.00095095095... $$\n$$ Sp_{min} = 0.999049049... $$\nRounding the result to $6$ significant figures, we get:\n$$ Sp_{min} \\approx 0.999049 $$\n\n**Explanation of Practical Difficulty**\n\nThe derived condition $Sp \\ge 1 - \\frac{Se \\cdot \\pi}{1 - \\pi}$ provides direct insight into why achieving a high $\\mathrm{PPV}$ is difficult in low-prevalence settings.\n1.  When prevalence $\\pi$ is very small (i.e., $\\pi \\to 0$), the denominator $(1 - \\pi)$ approaches $1$.\n2.  The numerator $Se \\cdot \\pi$ also becomes very small.\n3.  Consequently, the entire fraction $\\frac{Se \\cdot \\pi}{1 - \\pi}$ becomes a very small positive number.\n4.  The condition thus requires $Sp \\ge 1 - (\\text{a very small positive number})$. This means $Sp$ must be extremely close to $1$.\n\nIn this specific problem, the required specificity is greater than $0.999$. This implies that the test's false positive rate, $1 - Sp$, must be less than $1 - 0.999049 = 0.000951$, or approximately $0.095\\%$. Developing and mass-producing a diagnostic test that achieves such an exceptionally low false positive rate is technically challenging and often prohibitively expensive. In a low-prevalence population, the number of disease-free individuals is vastly larger than the number of diseased individuals. Even a tiny false positive rate, when applied to a very large number of healthy people, generates a substantial absolute number of false positives. These false positives can easily outnumber the true positives, which are inherently few due to the low prevalence, thus driving the $\\mathrm{PPV}$ down.", "answer": "$$\\boxed{0.999049}$$", "id": "4602477"}, {"introduction": "Populations are rarely uniform, and this exercise introduces the real-world complexity of heterogeneity. You will calculate the Positive Predictive Value ($PPV$) for distinct risk strata and for the combined population, revealing how an overall predictive value can mask important subgroup differences [@problem_id:4602501].", "problem": "A binary diagnostic test with constant characteristics across groups is applied to a two-stratum population. Each stratum comprises an equal share of the total population. In both strata, the test has sensitivity (Se) $Se = 0.9$ and specificity (Sp) $Sp = 0.95$. The disease prevalence (denote prevalence by $\\pi$) is $\\pi_1 = 0.2$ in stratum $1$ and $\\pi_2 = 0.01$ in stratum $2$. Let PPV denote the positive predictive value, defined as the probability that an individual has the disease given a positive test result.\n\nStarting only from the formal probabilistic definitions of sensitivity, specificity, prevalence, and positive predictive value as conditional probabilities, and using basic probability rules, do the following:\n- Derive an expression for the positive predictive value in a single stratum in terms of $Se$, $Sp$, and $\\pi$.\n- Compute the positive predictive values $PPV_1$ and $PPV_2$ for strata $1$ and $2$, respectively.\n- Treating the combined population as a mixture of the two equal-sized strata, compute the overall positive predictive value for the combined population, and compare it qualitatively to $PPV_1$ and $PPV_2$ to illustrate how prevalence influences positive predictive value.\n\nReport only the overall positive predictive value for the combined population as your final numeric answer. Express it as a decimal and round your final numeric answer to four significant figures.", "solution": "The problem statement is scientifically grounded, well-posed, and contains all necessary information for a unique solution. It is a standard application of conditional probability and Bayes' theorem to the field of epidemiology. We will proceed with the solution.\n\nLet $D$ be the event that an individual has the disease, and let $D^c$ be the event that the individual does not have the disease. Let $T^+$ be the event that the diagnostic test result is positive. Let $S_i$ be the event that an individual is from stratum $i$, where $i \\in \\{1, 2\\}$.\n\nThe problem provides the following quantities, formally defined as conditional probabilities:\n- Sensitivity ($Se$): $P(T^+|D) = Se = 0.9$. This is the probability of a positive test given the disease is present.\n- Specificity ($Sp$): $P(T^-|D^c) = Sp = 0.95$, where $T^-$ is a negative test. From this, the probability of a positive test given the disease is absent (the false positive rate) is $P(T^+|D^c) = 1 - Sp = 1 - 0.95 = 0.05$.\n- Prevalence ($\\pi$): $P(D) = \\pi$. For the two strata, we have $\\pi_1 = P(D|S_1) = 0.2$ and $\\pi_2 = P(D|S_2) = 0.01$.\n- Positive Predictive Value ($PPV$): $P(D|T^+) = PPV$. This is the probability that an individual has the disease given a positive test result.\n\nThe strata are of equal size, so the probability of an individual being from either stratum is $P(S_1) = P(S_2) = \\frac{1}{2} = 0.5$.\n\n**Derivation of PPV for a Single Stratum**\nThe positive predictive value, $PPV$, is defined by the conditional probability $P(D|T^+)$. Using the definition of conditional probability (Bayes' rule):\n$$ PPV = P(D|T^+) = \\frac{P(D \\cap T^+)}{P(T^+)} $$\nThe numerator, $P(D \\cap T^+)$, is the joint probability of having the disease and testing positive. It can be expressed as:\n$$ P(D \\cap T^+) = P(T^+|D) P(D) = Se \\cdot \\pi $$\nThe denominator, $P(T^+)$, is the total probability of a positive test. It can be found using the law of total probability, conditioning on the disease status:\n$$ P(T^+) = P(T^+|D)P(D) + P(T^+|D^c)P(D^c) $$\nSubstituting the definitions of sensitivity, specificity, and prevalence:\n$$ P(T^+) = (Se \\cdot \\pi) + ( (1-Sp) \\cdot (1-\\pi) ) $$\nCombining the numerator and denominator gives the general expression for PPV in terms of $Se$, $Sp$, and $\\pi$:\n$$ PPV = \\frac{Se \\cdot \\pi}{Se \\cdot \\pi + (1-Sp)(1-\\pi)} $$\n\n**Computation of $PPV_1$ and $PPV_2$**\nFor stratum $1$, with $\\pi_1 = 0.2$, $Se = 0.9$, and $Sp = 0.95$:\n$$ PPV_1 = \\frac{0.9 \\cdot 0.2}{0.9 \\cdot 0.2 + (1-0.95)(1-0.2)} = \\frac{0.18}{0.18 + (0.05)(0.8)} = \\frac{0.18}{0.18 + 0.04} = \\frac{0.18}{0.22} = \\frac{9}{11} \\approx 0.8182 $$\nFor stratum $2$, with $\\pi_2 = 0.01$, $Se = 0.9$, and $Sp = 0.95$:\n$$ PPV_2 = \\frac{0.9 \\cdot 0.01}{0.9 \\cdot 0.01 + (1-0.95)(1-0.01)} = \\frac{0.009}{0.009 + (0.05)(0.99)} = \\frac{0.009}{0.009 + 0.0495} = \\frac{0.009}{0.0585} = \\frac{2}{13} \\approx 0.1538 $$\n\n**Qualitative Comparison**\nThe results show a stark contrast: $PPV_1 \\approx 81.8\\%$ while $PPV_2 \\approx 15.4\\%$. This illustrates the profound influence of prevalence on the positive predictive value. In the high-prevalence setting ($\\pi_1 = 20\\%$), a positive test is highly indicative of disease. In the low-prevalence setting ($\\pi_2 = 1\\%$), a positive test is far more likely to be a false positive than a true positive.\n\n**Computation of an Overall Positive Predictive Value**\nTo find the overall PPV for the combined population, denoted $PPV_{overall}$, we must calculate the overall probability of having the disease and testing positive, $P(D \\cap T^+)$, and divide it by the overall probability of testing positive, $P(T^+)$. We use the law of total probability, conditioning on the strata.\n\nThe numerator is the overall probability of a true positive result:\n$$ P(D \\cap T^+) = P(D \\cap T^+ | S_1)P(S_1) + P(D \\cap T^+ | S_2)P(S_2) $$\nWithin each stratum $i$, $P(D \\cap T^+ | S_i) = P(T^+|D,S_i)P(D|S_i) = Se \\cdot \\pi_i$, since $Se$ is constant.\n$$ P(D \\cap T^+) = (Se \\cdot \\pi_1)P(S_1) + (Se \\cdot \\pi_2)P(S_2) $$\n$$ P(D \\cap T^+) = (0.9 \\cdot 0.2)(0.5) + (0.9 \\cdot 0.01)(0.5) = (0.18)(0.5) + (0.009)(0.5) = 0.09 + 0.0045 = 0.0945 $$\n\nThe denominator is the overall probability of a positive test result, regardless of disease status:\n$$ P(T^+) = P(T^+|S_1)P(S_1) + P(T^+|S_2)P(S_2) $$\nThe term $P(T^+|S_i)$ is the denominator from the stratum-specific PPV calculation.\n$P(T^+|S_1) = Se \\cdot \\pi_1 + (1-Sp)(1-\\pi_1) = 0.22$.\n$P(T^+|S_2) = Se \\cdot \\pi_2 + (1-Sp)(1-\\pi_2) = 0.0585$.\n$$ P(T^+) = (0.22)(0.5) + (0.0585)(0.5) = 0.11 + 0.02925 = 0.13925 $$\n\nFinally, the overall PPV is the ratio of these two probabilities:\n$$ PPV_{overall} = \\frac{P(D \\cap T^+)}{P(T^+)} = \\frac{0.0945}{0.13925} \\approx 0.678635549... $$\nRounding to four significant figures, the overall positive predictive value is $0.6786$. This value lies between $PPV_1$ and $PPV_2$ and is a weighted average, skewed towards $PPV_1$ because the higher prevalence in stratum $1$ causes it to contribute a larger proportion of the total positive tests.", "answer": "$$\\boxed{0.6786}$$", "id": "4602501"}]}